# A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.

> **NCT05345509** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Inventage Lab., Inc.** · enrollment: 62 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Aricept Tablet
- **DRUG:** IVL3003
- **DRUG:** IVL3003

## Key facts

- **NCT ID:** NCT05345509
- **Lead sponsor:** Inventage Lab., Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-01
- **Primary completion:** 2025-11-13
- **Final completion:** 2025-11-13
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2024-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05345509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05345509, "A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05345509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*